The Abu Dhabi Stem Cells Center (ADSCC) and Miltenyi have signed a Memorandum of Understanding (MoU) to advance the development and local manufacturing of chimeric antigen receptor T-cell (CAR-T) therapies in the UAE, building on ADSCC’s established advanced cell therapy capabilities and
